L-VIS

L-VIS is a medical technology company specializing in the development of artificial intelligence-based software for ophthalmologists. The firm's core product is a diagnostic aid designed to analyze retinal images, such as those from optical coherence tomography (OCT) scans, to detect and monitor age-related macular degeneration (AMD), one of the leading causes of vision loss in individuals over 50.

Founded in 2017 by Elie Lobel, a graduate of École Polytechnique and holder of a PhD in neurosciences, and Julien Siesse, L-VIS aims to improve the early and accurate diagnosis of retinal pathologies. The company's software assists ophthalmologists and orthoptists by providing rapid, reliable, and objective analysis of medical images, facilitating better patient management and treatment follow-up. The technology is being developed to integrate seamlessly into the existing workflows of ophthalmology practices.

The company has been supported by the SATT Paris-Saclay, an organization that accelerates the transfer of technology from academic research to industry. L-VIS collaborates with a scientific council composed of prominent ophthalmologists to ensure the clinical relevance and efficacy of its solutions.

Keywords: medical imaging, ophthalmology, artificial intelligence, retinal diagnostics, macular degeneration, OCT analysis, diagnostic software, MedTech, clinical decision support, eye care